GBM tumor cells also modulate the TME to promote an anti-inflammatory response by downregulating pro-inflammatory cytokines such as TNFα and TNF-related apoptosis-inducing ligand (TRAIL), inhibiting apoptosis and immune response [130]. The gene discussed is TNFSF10; the disease is neoplasm.